Abstract
We evaluated 14 children on long-term peritoneal dialysis for ototoxicity associated with aminoglycoside (AG) therapy. Baseline evaluation of all patients and 7 controls included pure-tone audiometry (PTA) and click-evoked auditory brain stem response (ABR). Nine patients had repeat PTA and ABR evaluations and vestibular testing 1 year after study entry. Five patients had an additional assessment following intraperitoneal AG therapy. The baseline auditory function of the patients was significantly poorer than controls at 6.0 and 8.0 kHz by PTA (p<0.05), whereas the results of ABR testing were not different. Of the 14 patients, 4 (28%) had hearing loss, 3 of whom had a history of intravenous AG therapy. In contrast, none of the patients who received intraperitoneal AG therapy only, or without a history of AG therapy, had hearing loss (P<0.005). There was no evidence of progressive loss of hearing acuity with time or associated with intraperitoneal AG therapy. One patient had findings of vestibular dysfunction. We conclude that children receiving peritoneal dialysis are at risk of AG ototoxicity. While intraperitoneal administration of AG may be associated with less ototoxicity than intravenous administration, further study is necessary to verify this finding and close monitoring of AG levels remains mandatory irrespective of the route of administration. PTA rather than click-evoked ABR appears to be the best indicator of abnormal hearing acuity in this population.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hawkins JE Jr (1976) Drug otoxicity. In: Keidel WD, Neff WD (eds) Handbook of sensory physiology, vol 5. Springer, New York Berlin Heidelberg, pp 707–748
Jackson GG, Arcieri G (1971) Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. J Infect Dis 124: S130-S137
Nikolaidis P, Vas S, Lawson V, Kennedy-Vosu L, Bernard A, Abraham G, Izatt S, Khanna S, Bargman JM, Oreopoulos DG (1991) Is intraperitoneal tobramycin ototoxic in CAPD patients? Perit Dial Int 11: 156–161
Salmon RF, Arant BS (1988) Aminoglycoside-related neurosensory hearing loss (NHL) in pediatric dialysis patients (abstract). Kidney Int 33: 249
Neu HC, Bendush CL (1976) Ototoxicity of tobramycin: a clinical overview. J Infect Dis 134: S206-S218
Brogard JM, Conraux C, Collard M, Lavillaureix J (1982) Ototoxicity of tobramycin in humans — influence of renal impairment. Int J Clin Pharmacol Ther Toxicol 20: 408–416
Johnson JT, Kamerer DB (1985) Aminoglycoside ototoxicity — an update, with implications for all drug therapies. Postgrad med 77: 131–138
Rybak LP (1986) Drug ototoxicity. Annu Rev Pharmacol Toxicol 26: 79–99
Gailiunas P, Dominguez-Morena M, Lazarus M, Lowrie EG, Gottlieb MN, Merrill JP (1978) Vestibular toxicity of gentamicin —incidence in patients receiving long-term hemodialysis therapy. Arch Intern Med Vol 138: 1621–1624
Sataloff J, Wagner S, Menduke H (1964) Kanamycin ototoxicity in healthy men. Arch Otolaryngol 80: 413–417
Brummett RE (1981) Effects of antibiotic-diuretic interactions in the guinea pig model of ototoxicity. Rev Infect Dis 3: S216–223
Black RE, Lau WK, Weinstein RJ, Young LS, Hewitt WL (1976) Ototoxicity of Amikacin. Antimicrob Agents Chemother 9: 956–961
Henry KR, Guess MB, Chole RA (1983) Hyperthermia increases aminoglycoside ototoxicity. Acta Otolaryngol (Stockh) 95: 323–327
Fee WE Jr (1980) Aminoglycoside ototoxicity in the human. Laryngoscope 90 [Suppl 24]: 1–9
Jauhiainen T, Kohonen A, Jauhiainen M (1972) Combined effects of noise and neomycin on the chochlea. Acta Otolaryngol (Stockh) 73: 387–390
Moore RD, Smith CR, Lietman PS (1984) Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis 149: 23–30
Black J, Calesnick B, Williams D, Weinstein M (1963) Pharmacology of gentamicin: a new broad-spectrum antibiotic. Antimicrob agents Chemother 8: 138–147
Federspel P, Schatzle W, Tiesler E (1976) Pharmacokinetics and ototoxicity of gentamicin, tobramycin and amikacin. J Infect Dis 134: S200-S205
Chong TK, Piranio B, Bernardini J (1991) Vestibular toxicity due to gentamicin in peritoneal dialysis patients. Perit Dial Int 11: 152–155
Koegel L (1985) Ototoxicity: a contemporary review of aminogly cosides, loop diuretics, acetylicylic acid, quinine, erythromycin, and cisplatinum. Am J Otol 6: 190–199
Kohelet D, Usher M, Arbel E, Arlazoroff A, Goldberg M (1990) Effect of gentamicin on the auditory brainstem evoked response in term infants: a preliminary report. Pediatr Res 28: 232–234
Sorkin MI (1988) Aminoglycosides, ototoxicity, and peritoneal dialysis. Semin Dial 1: 185–186
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Warady, B.A., Reed, L., Murphy, G. et al. Aminoglycoside ototoxicity in pediatric patients receiving long-term peritoneal dialysis. Pediatr Nephrol 7, 178–181 (1993). https://doi.org/10.1007/BF00864390
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00864390